Internal Medicine, Gastroenterology · Tulsa, OK
NPI
1154611457
Since 2011
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
4200 E Skelly Dr Ste 700
Tulsa, OK, 74135
Phone (918) 481-4700
Groups this clinician bills Medicare through
Medicare paid, 2024
$176K
7,378 services
Medicare patients, 2024
415
Average age 71
Drug cost, 2024
$307K
727 prescriptions
Company payments, 2025
$1,255
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aatish M Patel was code 99214 (office e&m - established), 163 times for 115 patients. In total Aatish M Patel billed 7,378 services in 32 codes, and Medicare paid $176K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-07-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 163 | 115 | $80.47 | $13K |
| 99204 Office E&M - New | Office | 134 | 134 | $98.59 | $13K |
| 43239 Upper GI Endoscopy | Facility | 111 | 107 | $61.69 | $6,847 |
| 45385 Colonoscopy - Lesion Removal | Facility | 97 | 95 | $191.81 | $19K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 56 | 22 | $46.42 | $2,600 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 53 | 18 | $35.38 | $1,875 |
| 45380 Lower GI Endoscopy - Other | Facility | 49 | 48 | $71.49 | $3,503 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 31 | 30 | $151.35 | $4,692 |
| 45378 Lower GI Endoscopy - Other | Facility | 24 | 23 | $116.65 | $2,800 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 23 | 23 | $161.31 | $3,710 |
| 99213 Office E&M - Established | Facility | 20 | 19 | $47.70 | $954 |
| 43251 Upper GI Endoscopy | Facility | 18 | 18 | $120.57 | $2,170 |
By year: 2022 $144K for 4,296 services; 2023 $151K for 6,086 services; 2024 $176K for 7,378 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aatish M Patel prescribed most often to Medicare patients was Rabeprazole Sodium, with 222 prescriptions and refills. In total Aatish M Patel wrote 727 Medicare prescriptions that cost $307K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rabeprazole Sodium Generic | 222 | 562 | 114 | $12K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 113 | 113 | 106 | $1,688 |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 70 | 70 | 66 | $1,110 |
| Pantoprazole Sodium Generic | 56 | 162 | 31 | $592 |
| Esomeprazole Magnesium Generic | 24 | 68 | 12 | $806 |
| Omeprazole Generic | 23 | 33 | Under 11 | $304 |
| Linzess Linaclotide | 21 | 27 | Under 11 | $14K |
| Famotidine Generic | 16 | 37 | Under 11 | $337 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 15 | 15 | 14 | $2,531 |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 13 | 13 | 13 | $182 |
| Lansoprazole Generic | 12 | 36 | Under 11 | $235 |
| Lubiprostone Generic | 12 | 16 | Under 11 | $1,123 |
| Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C | 12 | 12 | 12 | $1,653 |
Brand drugs: 167 claims; generic drugs: 560 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aatish M Patel $1,255 ($1,255 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $423.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 31 | $423 |
| Pfizer Inc. PFE | 9 | $179 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 7 | $147 |
| Lilly USA, LLC LLY | 5 | $104 |
| Janssen Biotech, Inc. JNJ | 5 | $89.37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 4 | $71.18 |
| Aimmune Therapeutics, Inc. | 2 | $56.71 |
| QOL Medical, LLC | 1 | $28.5 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $24.45 |
| Medtronic, Inc. MDT | 1 | $23.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.